Nishimura Yuhei, Inagaki Masaki
Department of Integrative Pharmacology, Mie University Graduate School of Medicine.
Glocal Center for Advanced Medical Research, Mie University.
Nihon Yakurigaku Zasshi. 2021;156(1):4-8. doi: 10.1254/fpj.20072.
The ubiquitin system regulates a wide variety of cellular functions. Not surprisingly, dysregulation of the ubiquitin system is associated with various disorders. Therefore, drugs that can modulate the functions of the ubiquitin system have been actively developed to treat these disorders. Chemical knockdown of pathogenic proteins using the ubiquitin-proteasome system is also a promising approach. The ubiquitin system regulates the assemble and disassemble of primary cilia through balanced control over the ubiquitination and deubiquitination of ciliary proteins. Primary cilia are antenna-like structures present in many vertebrate cells that sense and transduce extracellular cues to control cellular processes such as proliferation and differentiation. Impairment of primary cilia is associated with many diseases, including cancer and ciliopathy, a group of multisystem developmental disorders. In this review, we focus on the role of the ubiquitin system on cilia-related disorders and discuss the possibility of the ubiquitin system as therapeutic targets for these diseases through regulation of primary cilia formation.
泛素系统调节多种细胞功能。毫不奇怪,泛素系统的失调与各种疾病相关。因此,能够调节泛素系统功能的药物已被积极开发用于治疗这些疾病。利用泛素 - 蛋白酶体系统对致病蛋白进行化学敲低也是一种有前景的方法。泛素系统通过对纤毛蛋白的泛素化和去泛素化进行平衡控制,调节初级纤毛的组装和拆卸。初级纤毛是存在于许多脊椎动物细胞中的天线样结构,可感知并转导细胞外信号以控制细胞过程,如增殖和分化。初级纤毛的损伤与许多疾病相关,包括癌症和纤毛病(一组多系统发育障碍疾病)。在本综述中,我们重点关注泛素系统在纤毛相关疾病中的作用,并通过调节初级纤毛形成来探讨泛素系统作为这些疾病治疗靶点的可能性。